Want to join the conversation?
$PFG said that at the end of 2Q16, trailing 12-month ROE, excluding AOCI other than foreign currency translation adjustments, was 13.3%. This was down 140 BP from 2Q15, reflecting flat equity markets, a strong US dollar and lower prepayment activity.
$BABA seems to be on a roll! But increasing its yearly sales outlook from 48% to 54% seems over-expectation from the company's part, doesn't it?
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?